ID 112935
Title Alternative
The role of Pim-2 in myeloma bone destruction
Author
Oda, Asuka Tokushima University
Amachi, Ryota Tokushima University
Iwasa, Masami Tokushima University
Keywords
myeloma
Pim‐2
receptor activator of NF‐κB ligand
osteoclastogenesis
bone destruction
Content Type
Journal Article
Journal Title
British Journal of Haematology
ISSN
13652141
00071048
NCID
AA11618011
AA00574570
Publisher
John Wiley & Sons Ltd
Volume
180
Issue
4
Start Page
581
End Page
585
Published Date
2016-10-17
Remark
This is the peer reviewed version of the following article: Teramachi, J. , Hiasa, M. , Oda, A. , Harada, T. , Nakamura, S. , Amachi, R. , Tenshin, H. , Iwasa, M. , Fujii, S. , Kagawa, K. , Miki, H. , Kurahashi, K. , Yoshida, S. , Endo, I. , Haneji, T. , Matsumoto, T. and Abe, M. (2018), Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma. Br J Haematol, 180: 581-585, which has been published in final form at https://doi.org/10.1111/bjh.14388. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Author
departments
Oral Sciences
University Hospital
Medical Sciences
Institute of Advanced Medical Sciences